145 related articles for article (PubMed ID: 38419066)
1. Unlocking hepatocellular carcinoma aggression: STAMBPL1-mediated TRAF2 deubiquitination activates WNT/PI3K/NF-kb signaling pathway.
Wang Z; Zhang Y; Shen Y; Zhou H; Gao Y; Zhu C; Qin X
Biol Direct; 2024 Feb; 19(1):18. PubMed ID: 38419066
[TBL] [Abstract][Full Text] [Related]
2. STAM-binding Protein-like 1 Promotes Growth and Migration of Colorectal Cancer by NF-κB Pathway.
Zhou X; Cheng Y; Kang J; Mao G
Protein Pept Lett; 2023; 30(12):1058-1066. PubMed ID: 38008943
[TBL] [Abstract][Full Text] [Related]
3. The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway.
Liang X; Yao J; Cui D; Zheng W; Liu Y; Lou G; Ye B; Shui L; Sun Y; Zhao Y; Zheng M
Cell Death Differ; 2023 Jun; 30(6):1550-1562. PubMed ID: 37081115
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.
Xiao N; Li H; Luo J; Wang R; Chen H; Chen J; Wang P
Biochem J; 2012 Feb; 441(3):979-86. PubMed ID: 22029577
[TBL] [Abstract][Full Text] [Related]
5. An RNA interference screen identifies the Deubiquitinase STAMBPL1 as a critical regulator of human T-cell leukemia virus type 1 tax nuclear export and NF-κB activation.
Lavorgna A; Harhaj EW
J Virol; 2012 Mar; 86(6):3357-69. PubMed ID: 22258247
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
7. TRIM25 Promotes TNF-α-Induced NF-κB Activation through Potentiating the K63-Linked Ubiquitination of TRAF2.
Liu Y; Liu K; Huang Y; Sun M; Tian Q; Zhang S; Qin Y
J Immunol; 2020 Mar; 204(6):1499-1507. PubMed ID: 32024699
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
9. Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation.
Chen X; Shi H; Bi X; Li Y; Huang Z
Cancer Lett; 2019 Aug; 456():49-58. PubMed ID: 31004702
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori-induced reactive oxygen species direct turnover of CSN-associated STAMBPL1 and augment apoptotic cell death.
Chaithongyot S; Naumann M
Cell Mol Life Sci; 2022 Jan; 79(2):86. PubMed ID: 35066747
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
[TBL] [Abstract][Full Text] [Related]
12. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
13. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
Yang CH; Murti A; Pfeffer LM
J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
[TBL] [Abstract][Full Text] [Related]
14. Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.
Dhingra R; Rabinovich-Nikitin I; Rothman S; Guberman M; Gang H; Margulets V; Jassal DS; Alagarsamy KN; Dhingra S; Valenzuela Ripoll C; Billia F; Diwan A; Javaheri A; Kirshenbaum LA
Circulation; 2022 Sep; 146(12):934-954. PubMed ID: 35983756
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
16. TRAF2 regulates the cytoplasmic/nuclear distribution of TRAF4 and its biological function in breast cancer cells.
Zhang X; Wen Z; Sun L; Wang J; Song M; Wang E; Mi X
Biochem Biophys Res Commun; 2013 Jun; 436(2):344-8. PubMed ID: 23743189
[TBL] [Abstract][Full Text] [Related]
17. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
18. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
Lei T; Zhu X; Zhu K; Jia F; Li S
Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
[TBL] [Abstract][Full Text] [Related]
19. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
20. TRAF2 is an NF-κB-activating oncogene in epithelial cancers.
Shen RR; Zhou AY; Kim E; O'Connell JT; Hagerstrand D; Beroukhim R; Hahn WC
Oncogene; 2015 Jan; 34(2):209-16. PubMed ID: 24362534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]